Muscle PARP1 inhibition extends lifespan through AMPKα PARylation and activation in Drosophila .
Shanshan GuoShuang ZhangYixiao ZhuangFamin XieRuwen WangXingyu KongQiongyue ZhangYonghao FengHuanqing GaoXingxing KongTiemin LiuPublished in: Proceedings of the National Academy of Sciences of the United States of America (2023)
Poly(ADP-ribose) polymerase-1 (PARP1) has been reported to play an important role in longevity. Here, we showed that the knockdown of the PARP1 extended the lifespan of Drosophila , with particular emphasis on the skeletal muscle. The muscle-specific mutant Drosophila exhibited resistance to starvation and oxidative stress, as well as an increased ability to climb, with enhanced mitochondrial biogenesis and activity at an older age. Mechanistically, the inhibition of PARP1 increases the activity of AMP-activated protein kinase alpha (AMPKα) and mitochondrial turnover. PARP1 could interact with AMPKα and then regulate it via poly(ADP ribosyl)ation (PARylation) at residues E155 and E195. Double knockdown of PARP1 and AMPKα, specifically in muscle, could counteract the effects of PARP1 inhibition in Drosophila . Finally, we showed that increasing lifespan via maintaining mitochondrial network homeostasis required intact PTEN induced kinase 1 (PINK1). Taken together, these data indicate that the interplay between PARP1 and AMPKα can manipulate mitochondrial turnover, and be targeted to promote longevity.
Keyphrases
- skeletal muscle
- dna damage
- oxidative stress
- protein kinase
- dna repair
- diabetic rats
- insulin resistance
- ischemia reperfusion injury
- cell proliferation
- physical activity
- cancer therapy
- drug delivery
- machine learning
- adipose tissue
- body composition
- induced apoptosis
- metabolic syndrome
- big data
- endoplasmic reticulum stress
- heat shock protein